ABIONYX Pharma SA (EPA:ABNX)
France
· Delayed Price · Currency is EUR 1.222
-0.016 (-1.29%)
May 6, 2025, 4:57 PM CET
ABIONYX Pharma Revenue
In the year 2024, ABIONYX Pharma had annual revenue of 4.55M EUR, down -1.92%. ABIONYX Pharma had revenue of 2.21M in the half year ending December 31, 2024, a decrease of -15.83%.
Revenue
4.55M
Revenue Growth
-1.92%
P/S Ratio
9.43
Revenue / Employee
89.24K
Employees
51
Market Cap
42.93M
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sanofi | 45.17B |
| EssilorLuxottica Société anonyme | 26.51B |
| Sartorius Stedim Biotech | 2.86B |
| bioMérieux | 3.98B |
| Eurofins Scientific SE | 6.95B |
| Ipsen | 3.57B |
| Virbac | 1.40B |
| emeis Société anonyme | 5.64B |